Canada vs New Zealand: Proportion of isolates with resistance to azithromycin reported to
Canada
6.1
in 2020
New Zealand
6.5
in 2020
Canada rank
25th
New Zealand rank
24th
Proportion of isolates with resistance to azithromycin reported to over time
- Canada
- New Zealand
How they compare
New Zealand currently reports 6.5 against 6.1 in Canada, a difference of 0.4.
That makes New Zealand's figure about 1.1 times Canada's.
The two have swapped places 1 time across 6 shared years of data; in 2013 it was Canada ahead.
Canada ranks 25th and New Zealand ranks 24th of 47 countries.
Across the 2 decades both report, Canada averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Canada | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.64 | 4.52 | 1.13 | Canada |
| 2020s | 6.1 | 6.5 | 0.4 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Canada or New Zealand?
- New Zealand, at 6.5 against 6.1 in Canada as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Canada and New Zealand?
- 0.4, with New Zealand ahead.
- How many years of comparable data are there for Canada and New Zealand?
- 6 years are reported by both, from 2013 to 2020.
- How do Canada and New Zealand rank globally for proportion of isolates with resistance to azithromycin reported to?
- Canada ranks 25th and New Zealand ranks 24th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.